Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma

Histopathologic grade of mucoepidermoid carcinoma (MEC) is an established predictor of prognosis and affects treatment protocol. Tumor behavior is more aggressive in high‐grade than in low‐grade MEC, leading to a more intensive treatment protocol. Outcomes for patients with intermediate‐grade MEC are less clear; therefore, the optimal treatment protocol for this group is not well defined. The treatment protocol and survival outcomes of patients treated for MEC of the head and neck was investigated.

[1]  A. Mäkitie,et al.  Management and Outcome of Patients With Mucoepidermoid Carcinoma of Major Salivary Gland Origin: A Single Institution's 30‐Year Experience , 2008, The Laryngoscope.

[2]  Y. Hayashi,et al.  Identification of a novel fusion gene MLL‐MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23) , 2007, Genes, chromosomes & cancer.

[3]  H. Schackert,et al.  t(11;19)(q21;p12~p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma. , 2007, Journal of pediatric surgery.

[4]  J. Chan,et al.  Advances in salivary gland pathology , 2007, Histopathology.

[5]  R. Weber,et al.  Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma. , 2007, Archives of otolaryngology--head & neck surgery.

[6]  R. Fabian,et al.  Clinical Presentation, Management, and Outcome of High-Grade Mucoepidermoid Carcinoma of the Parotid Gland , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[7]  R. Nagler,et al.  TUNEL – an efficient prognosis predictor of salivary malignancies , 2007, British Journal of Cancer.

[8]  E. Patsouris,et al.  Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. , 2007, Oral oncology.

[9]  S. Etemad-Moghadam,et al.  Expression of p21WAF in Salivary Gland Mucoepidermoid Carcinoma and Its Relation to Histologic Grade , 2007, International journal of surgical pathology.

[10]  M. Teixeira,et al.  Recurrent fusion oncogenes in carcinomas. , 2006, Critical reviews in oncogenesis.

[11]  M. Luna.  Salivary Mucoepidermoid Carcinoma: Revisited , 2006, Advances in anatomic pathology.

[12]  F. Kaye,et al.  Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation , 2006, Oncogene.

[13]  Shigeo Nakamura,et al.  MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma , 2006, Clinical Cancer Research.

[14]  L. Kowalski,et al.  Clinicopathologic and Immunohistochemical Study of Intraoral Mucoepidermoid Carcinoma , 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[15]  L. Thompson.  Mucoepidermoid Carcinoma , 2005, Ear, nose, & throat journal.

[16]  L. Kowalski,et al.  PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. , 2004, International journal of oral and maxillofacial surgery.

[17]  Jun Yan.  Survival Analysis: Techniques for Censored and Truncated Data , 2004 .

[18]  V. Pankratz,et al.  Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience. , 2004, Archives of otolaryngology--head & neck surgery.

[19]  G. Tonon,et al.  t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.

[20]  G. Tonon,et al.  t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.

[21]  M. Urken,et al.  Mucoepidermoid Carcinoma: A Clinicopathologic Study of 80 Patients With Special Reference to Histological Grading , 2001 .

[22]  P. Auclair,et al.  Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria , 2000 .

[23]  R. Klapdor,et al.  TNM staging, histopathological grading, and tumor-associated antigens in patients with a history of mucoepidermoid carcinoma of the salivary glands. , 1999, Anticancer research.

[24]  G. Ellis,et al.  Mucoepidermoid carcinoma of the major salivary glands , 1998, Cancer.

[25]  R. Schmelzle,et al.  Mucoepidermoid carcinoma of salivary gland origin: classification, clinical-pathological correlation, treatment results and long-term follow-up in 55 patients. , 1996, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[26]  J. Batsakis,et al.  Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: A clinicopathologic and flow cytometric investigation , 1995, Head & neck.

[27]  S. Houle,et al.  A phase I dose escalation trial of yttrium‐90 microspheres in the treatment of primary hepatocellular carcinoma , 1992, Cancer.

[28]  G. Ellis,et al.  Mucoepidermoid carcinoma of intraoral salivary glands evaluation and application of grading criteria in 143 cases , 1992, Cancer.

[29]  R. Spiro,et al.  The importance of clinical staging of minor salivary gland carcinoma. , 1991, American journal of surgery.

[30]  J. Batsakis,et al.  Histopathologic Grading of Salivary Gland Neoplasms: I. Mucoepidermoid Carcinomas , 1990, The Annals of otology, rhinology, and laryngology.

[31]  R. Spiro,et al.  Cancer of the parotid gland. A clinicopathologic study of 288 primary cases. , 1975, American journal of surgery.

[32]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[33]  G. Swennen,et al.  Mucoepidermoid carcinoma of the salivary glands--clinical review of 42 cases. , 2005, Oral oncology.

[34]  H. Shirato,et al.  Role of radiotherapy for mucoepidermoid carcinoma of salivary gland. , 1999, Oral oncology.

[35]  R. Spiro.  Salivary neoplasms: overview of a 35-year experience with 2,807 patients. , 1986, Head & neck surgery.

[36]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .